Orbital involvement by NUT midline carcinoma: new presentation and encouraging outcome managed by radiotherapy combined with tyrosine kinase inhibitor: a case report

BACKGROUND: NUT midline carcinoma (NMC) is a poorly differentiated squamous cancer with a median survival at less than 7 months. NMC is resistant to conventional chemotherapies and characterized by rearrangement of the NUT gene. CASE PRESENTATION: Here, we described a patient who initially presented...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Peiwei, Zhou, Chuandi, Jia, Renbing, Wang, Yefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942267/
https://www.ncbi.nlm.nih.gov/pubmed/31900183
http://dx.doi.org/10.1186/s13000-019-0922-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942267/
https://www.ncbi.nlm.nih.gov/pubmed/31900183
http://dx.doi.org/10.1186/s13000-019-0922-1

Ejemplares similares